Detalhe da pesquisa
1.
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study).
Br J Dermatol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38660811
2.
Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma.
Pigment Cell Melanoma Res
; 34(5): 978-983, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449414
3.
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088741
4.
Diabetes and Blood Glucose Disorders Under Anti-PD1.
J Immunother
; 41(5): 232-240, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481423